Clinical Trials in Austin

Showing 4881-4900 of 11,561 trials

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT03657797

The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 ophthalmic solution in lowering intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Three different concentrations of NCX 470 ophthalmic solution (0.021%, 0.042%, and 0.065%) will be compared to latanoprost 0.005% ophthalmic solution.

Glaucoma, Open-AngleHypertension, Ocular

Nicox Ophthalmics, Inc.656 participantsStarted Aug 2018

Austin, Texas, United States

COMPLETEDPhase 2/3< 1 mile

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

NCT03472040

This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II Hereditary Angioedema (HAE).

Hereditary AngioedemaHAEProphylaxis

BioCryst Pharmaceuticals387 participantsStarted Feb 2018

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Bentonville, Arkansas, United States +84 more locations

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Find Trials by Condition in Austin

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Treatment of Moderate to Severe Glabellar Lines

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Treatment of Moderate to Severe Lateral Canthal Lines